Impact of different types of tree nut, peanut, and soy nut consumption on serum C-reactive protein (CRP): A systematic review and meta-analysis of randomized controlled clinical trials

Medicine (United States)

Volumn 95, Issue 44, 2016, Pages

  Mazidi, Mohsen ^a,b   Rezaie, Peyman ^c   Ferns, Gordon A ^d   Gao, Hong Kai ^e  

^a INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^b INSTITUTE OF GENETICS AND DEVELOPMENTAL BIOLOGY   (China)

^c MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d UNIVERSITY OF BRIGHTON   (United Kingdom)

^e GENERAL HOSPITAL OF CHINESE PEOPLE'S ARMED POLICE FORCES   (China)

Author keywords

C reactive protein; Meta analysis; Peanut; Tree nut

Indexed keywords

C REACTIVE PROTEIN;

ARACHIS; DIET; HUMAN; META ANALYSIS; NUT; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SOYBEAN;

ARACHIS; C-REACTIVE PROTEIN; DIET; HUMANS; NUTS; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SOYBEANS;

EID: 84995920169     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000005165     Document Type: Review

References (65)

1. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002;105:1135-43.
2. Pradhan A, Ridker P. Do atherosclerosis and type 2 diabetes share a common inflammatory basis? Eur Heart J 2002;23:831-4
3. Salas-Salvadó J, Casas-Agustench P, Murphy MM, et al. The effect of nuts on inflammation. Asia Pac J Clin Nutr 2008;17(suppl 1):333-6.
4. Haffner SM. The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease. Am J Cardiol 2006;97:3-11.
5. Hermsdorff HHM, Zulet MÁ, Abete I, et al. A legume-based hypocaloric diet reduces proinflammatory status and improves metabolic features in overweight/obese subjects. Eur J Nutr 2011;50:61-9.
6. Wolever TM, Gibbs AL, Mehling C, et al. The Canadian Trial of Carbohydrates in Diabetes (CCD), a 1-y controlled trial of low-glycemicindex dietary carbohydrate in type 2 diabetes: no effect on glycated hemoglobin but reduction in C-reactive protein. Am J Clin Nutr 2008;87:114-25.
7. Rizzo M, Rizvi AA, Rini GB, et al. The therapeutic modulation of atherogenic dyslipidemia and inflammatory markers in the metabolic syndrome: what is the clinical relevance? Acta Diabetologica 2009;46:1-1.
8. Fredrikson GN, Hedblad B, Nilsson J-Å, et al. Association between diet, lifestyle, metabolic cardiovascular risk factors, and plasma C-reactive protein levels. Metabolism 2004;53:1436-42.
9. Selvin E, Paynter NP, Erlinger TP. The effect of weight loss on C-reactive protein: a systematic review. Arch Int Med 2007;167:31-9.
10. Nakano S, Kuboki K, Matsumoto T, et al. Small, dense LDL and highsensitivity C-reactive protein (hs-CRP) in metabolic syndrome with type 2 diabetes mellitus. J Atheroscler Thromb 2010;17:410-5.
11. Erlinger TP, Miller ER, Charleston J, et al. Inflammation modifies the effects of a reduced-fat low-cholesterol diet on lipids results from the DASH-sodium trial. Circulation 2003;108:150-4.
12. Zhao G, Etherton TD, Martin KR, et al. Dietary a-linolenic acid reduces inflammatory and lipid cardiovascular risk factors in hypercholesterolemic men and women. J Nutr 2004;134:2991-7.
13. Lopez-Garcia E, Schulze MB, Manson JE, et al. Consumption of (n-3) fatty acids is related to plasma biomarkers of inflammation and endothelial activation in women. J Nutr 2004;134:1806-11.
14. Wells BJ,Mainous AG, Everett CJ. Association between dietary arginine and C-reactive protein. Nutrition 2005;21:125-30.
15. Ros E. Nuts: consumption, composition, health benefits and safety. CAB Rev 2008;3:1-2.
16. Kelly JH, Sabaté J. Nuts and coronary heart disease: an epidemiological perspective. Brit J Nutr 2006;96(S2):S61-7.
17. Jiang R, Jacobs DR, Mayer-Davis E, et al. Nut and seed consumption and inflammatory markers in the multi-ethnic study of atherosclerosis. Am J Epidemiol 2006;163:222-31.
18. Kris-Etherton PM, Hu FB, Ros E, et al. The role of tree nuts and peanuts in the prevention of coronary heart disease: multiple potential mechanisms. J Nutr 2008;138:1746S-51S.
19. Blomhoff R, Carlsen MH, Andersen LF, et al. Health benefits of nuts: potential role of antioxidants. Brit J Nutr 2006;96:S52-60.
20. Bernstein AM, Roizen MF, Martinez L. Purified palmitoleic acid for the reduction of high-sensitivity C-reactive protein and serum lipids: a double-blinded, randomized, placebo controlled study. J Clin Lipidol 2014;8:612-7.
21. Rajaram S, Connell KM, Sabaté J. Effect of almond-enriched highmonounsaturated fat diet on selected markers of inflammation: a randomised, controlled, crossover study. Brit J Nutr 2010;103:907-12.
22. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Int Med 2009;151:264-9.
23. Phan K, Tian DH, Cao C, et al. Systematic review and meta-analysis: techniques and a guide for the academic surgeon. Ann Cardiothorac Surg 2015;4:112.
24. Wiley Online Library, Higgins JP, Green S. Cochrane Handbook for Systematic Reviews of Interventions. Vol. 5. 2008.
25. Mohsen Mazidi EK, Peyman rezaie, Gordon A. Ferns. Treatment with GLP1 receptor agonists reduce serum CRP concentrations in patients with type 2 diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials. Journal of Diabetes and Its Complications. 2016. 10.1016/j.jdiacomp.2016.05.022, http://www.jdcjournal.com/ar ticle/S1056-8727(16)30175-1/abstract.
26. Joh Wiley & Sons Ltd., Higgins J, Green S. Cochrane Handbook for Systematic Reviews, version 5.0.2 The Cochrane Collaboration. 2009.
27. Hozo S, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 2005; 5: 1.
28. Sutton AJ, Abrams KR, Jones DR, et al. Methods for Meta-Analysis in Medical Research. Vol. 348. Chichester, UK:Wiley; 2000.
29. Ferretti G, Bacchetti T, Sahebkar A. Effect of statin therapy on paraoxonase-1 status: a systematic review and meta-analysis of 25 clinical trials. Progr Lipid Res 2015;60:50-73.
30. Sahebkar A. Are curcuminoids effective C-reactive protein-lowering agents in clinical practice? evidence from a meta-analysis. Phytother Res 2014;28:633-42.
31. Duval S, Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 2000;56:455-63.
32. Borenstein M, Hedges L, Higgins J, et al. Comprehensive Meta-analysis, version 2. 2005;Englewood, NJ:Biostat, 104.
33. Casas-Agustench P, López-Uriarte P, Bulló M, et al. Effects of one serving of mixed nuts on serum lipids, insulin resistance and inflammatory markers in patients with the metabolic syndrome. Nutr Metab Cardiovasc Dis 2011;21:126-35.
34. Colpo E, Vilanova CDD, Reetz LGB, et al. Brazilian nut consumption by healthy volunteers improves inflammatory parameters. Nutrition 2014;30:459-65.
35. Parham M, Heidari S, Khorramirad A, et al. Effects of pistachio nut supplementation on blood glucose in patients with type 2 diabetes: a randomized crossover trial. Rev Diabet Stud 2013;11:190-6.
36. Tapsell LC, Batterham M, Teuss G, et al. Long-term effects of increased dietary polyunsaturated fat from walnuts on metabolic parameters in type II diabetes. Eur J Clin Nutr 2009;63:1008-15.
37. Bakhtiary A, Yassin Z, Hanachi P, et al. Effects of soy on metabolic biomarkers of cardiovascular disease in elderly women with the metabolic syndrome. J Family Reprod Health 2010;4:95-104.
38. Reverri EJ, LaSalle CD, Franke AA, et al. Soy provides modest benefits on endothelial function without affecting inflammatory biomarkers in adults at cardiometabolic risk. Mol Nutr Food Res 2015;59:323-33.
39. Azadbakht L, Kimiagar M, Mehrabi Y, et al. Soy inclusion in the diet improves features of the metabolic syndrome: a randomized crossover study in postmenopausal women. Am J Clin Nutr 2007;85:735-41.
40. Azadbakht L, Kimiagar M, Mehrabi Y, et al. Soy consumption, markers of inflammation, and endothelial function: a cross-over study in postmenopausal women with the metabolic syndrome. Diabetes Care 2007;30:967-73.
41. Brennan AM, Sweeney LL, Liu X, et al. Walnut consumption increases satiation but has no effect on insulin resistance or the metabolic profile over a 4-day period. Obesity 2010;18:1176-82.
42. Aronis KN, Vamvini MT, Chamberland JP, et al. Short-term walnut consumption increases circulating total adiponectin and apolipoprotein A concentrations, but does not affect markers of inflammation or vascular injury in obese humans with the metabolic syndrome: data from a double-blinded, randomized, placebo-controlled study. Metabolism 2012;61:577-82.
43. Ros E, Núñez I, Pérez-Heras A, et al. A walnut diet improves endothelial function in hypercholesterolemic subjects a randomized crossover trial. Circulation 2004;109:1609-14.
44. Wu L, Piotrowski K, Rau T, et al. Walnut-enriched diet reduces fasting non-HDL-cholesterol and apolipoprotein B in healthy Caucasian subjects: a randomized controlled cross-over clinical trial. Metabolism 2014;63:382-91.
45. Chiang Y-L, Haddad E, Rajaram S, et al. The effect of dietary walnuts compared to fatty fish on eicosanoids, cytokines, soluble endothelial adhesion molecules and lymphocyte subsets: a randomized, controlled crossover trial. Prostaglandins Leukot Essent Fatty Acids 2012;87: 111-7.
46. Jenkins DJ, Kendall CW, Marchie A, et al. Dose response of almonds on coronary heart disease risk factors: blood lipids, oxidized low-density lipoproteins, lipoprotein (a), homocysteine, and pulmonary nitric oxide a randomized, controlled, crossover trial. Circulation 2002;106:1327-32.
47. Sauder KA, McCrea CE, Ulbrecht JS, et al. Effects of pistachios on the lipid/lipoprotein profile, glycemic control, inflammation, and endothelial function in type 2 diabetes: a randomized trial. Metabolism 2015;64:1521-9.
48. Hernández-Alonso P, Salas-Salvadó J, Baldrich-MoraM, et al. Beneficial effect of pistachio consumption on glucose metabolism, insulin resistance, inflammation, and related metabolic risk markers: a randomized clinical trial. Diabetes Care 2014;37:3098-105.
49. Kasliwal RR, Bansal M, Mehrotra R, et al. Effect of pistachio nut consumption on endothelial function and arterial stiffness. Nutrition 2015;31:678.
50. Gulati S, Misra A, Pandey RM, et al. Effects of pistachio nuts on body composition, metabolic, inflammatory and oxidative stress parameters in Asian Indians with metabolic syndrome: a 24-wk, randomized control trial. Nutrition 2014;30:192-7.
51. Lee YJ, Nam GE, Seo JA, et al. Nut consumption has favorable effects on lipid profiles of Korean women with metabolic syndrome. Nutr Res 2014;34:814-20.
52. Moreira Alves RD, Boroni Moreira AP, Macedo VS, et al. High-oleic peanuts: new perspective to attenuate glucose homeostasis disruption and inflammation related obesity. Obesity 2014;22:1981-8.
53. Tey SL, Gray AR, Chisholm AW, et al. The dose of hazelnuts influences acceptance and diet quality but not inflammatory markers and body composition in overweight and obese individuals. J Nutr 2013;143: 1254-62.
54. Pischon T, Hankinson SE, Hotamisligil GS, et al. Habitual dietary intake of n-3 and n-6 fatty acids in relation to inflammatory markers among US men and women. Circulation 2003;108:155-60.
55. Madsen T, Skou HA, Hansen VE, et al. C-reactive protein, dietary n-3 fatty acids, and the extent of coronary artery disease. Am J Cardiol 2001;88:1139-42.
56. Salas-Salvadó J, Garcia-Arellano A, Estruch R, et al. Components of the Mediterranean-type food pattern and serum inflammatory markers among patients at high risk for cardiovascular disease. Eur J Clin Nutr 2008;62:651-9.
57. Albert CM, Gaziano JM, Willett WC, et al. Nut consumption and decreased risk of sudden cardiac death in the Physicians' Health Study. Arch Intern Med 2002;162:1382-7.
58. Ellsworth J, Kushi L, Folsom A. Frequent nut intake and risk of death from coronary heart disease and all causes in postmenopausal women: the Iowa Women's Health Study. Nutr Metab Cardiovasc Dis 2001;11:372-7.
59. Dreher ML. Pistachio nuts: composition and potential health benefits. Nutr Rev 2012;70:234-40.
60. Kocyigit A, Koylu A, Keles H. Effects of pistachio nuts consumption on plasma lipid profile and oxidative status in healthy volunteers. Nutr Metab Cardiovasc Dis 2006;16:202-9.
61. Esposito K, Giugliano D. Diet and inflammation: a link to metabolic and cardiovascular diseases. Eur Heart J 2006;27:15-20.
62. Jenkins DJ, Kendall CW, Connelly PW, et al. Effects of high-and lowisoflavone (phytoestrogen) soy foods on inflammatory biomarkers and proinflammatory cytokines in middle-aged men and women. Metabolism 2002;51:919-24.
63. Mantzoros CS, Williams CJ, Manson JE, et al. Adherence to the Mediterranean dietary pattern is positively associated with plasma adiponectin concentrations in diabetic women. Am J Clin Nutr 2006;84:328-35.
64. Nuesch E, Trelle S, Reichenbach S, et al. Small study effects in metaanalyses of osteoarthritis trials: meta-epidemiological study. BMJ (Clinical Res Ed) 2010;341:c3515.
65. Sterne JA, Gavaghan D, Egger M. Publication and related bias in metaanalysis: power of statistical tests and prevalence in the literature. J Clin Epidemiol 2000;53:1119-29.